Skip to main content

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 11, Number 6, March 2004

Book review

Review article

Favourites:
ADD

Stochastic Algorithm for Kinase Homology Model Construction
pp. 675-692(18)
Authors: Rayan, A.; Noy, E.; Chema, D.; Levitzki, A.; Goldblum, A.

Favourites:
ADD

Virtual Screening for Kinase Targets
pp. 693-707(15)
Authors: Muegge, Ingo; Enyedy, Istvan J.

Favourites:
ADD

Property-Based Design of KDR Kinase Inhibitors
pp. 709-719(11)
Authors: Fraley, Mark E.; Hoffman, William F.; Arrington, Kenneth L.; Hungate, Randy W.; Hartman, George D.; McFall, Rosemary C.; Coll, Kathleen E.; Rickert, Keith; Thomas, Kenneth A.; McGaughey, Georgia B.

Favourites:
ADD

AlphaScreen™ Kinase HTS Platforms
pp. 721-730(10)
Authors: Warner, Greg; Illy, Chantal; Pedro, Liliana; Roby, Philippe; Bosse, Roger

Favourites:
ADD
Favourites:
ADD

4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck
pp. 747-753(7)
Authors: Moffat, D. F.C.; Allen, R. A.; Rapecki, S. E.; Davis, P. D.; O'Connell, J.; Hutchings, M. C.; King, M. A.; Boyce, B. A.; Perry, M. J.

Favourites:
ADD

GSK-3 Inhibitors: Discoveries and Developments
pp. 755-763(9)
Authors: Alonso, M.; Martinez, A.

Favourites:
ADD

Challenges in Antimicrobial Drug Discovery and the Potential of Nucleoside Antibiotics
pp. 775-793(19)
Authors: Rachakonda, Suguna; Cartee, Leanne

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more